Coherus Oncology, Inc. (CHRS) Free Cash Flow
Coherus Oncology, Inc. (CHRS) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2016-12-31 | -$263.37M |
| 2017-12-31 | -$202.60M |
| 2018-12-31 | -$156.86M |
| 2019-12-31 | $26.53M |
| 2020-12-31 | $147.09M |
| 2021-12-31 | -$38.72M |
| 2022-12-31 | -$241.12M |
| 2023-12-31 | -$174.88M |
| 2024-12-31 | $207.38M |
| 2025-12-31 | $331.79M |
How CHRS compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| BRKR | Bruker Corporation | $43.30M |
| KURA | Kura Oncology Inc. | -$70.70M |
| IDYA | IDEAYA Biosciences Inc. | -$73.47M |
| AXSM | Axsome Therapeutics Inc. | -$93.89M |
| RGNX | REGENXBIO Inc. | -$126.38M |
These are five companies in the same sector as CHRS with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Coherus Oncology, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("CHRS", 2025, "")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | CHRS | $1.05 | -1.87% | 1.72M |
| 3 | ||||
| 4 | ||||
| 5 |